Top Markets
Coin of the day
Egetis Therapeutics AB (publ) Egetis Therapeutics AB (publ)

Egetis Therapeutics AB (publ)

EGTX
Hisse Senetlerindeki Sıralama #14551
Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to... Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to progressing drug development, primarily focusing on late-stage projects. The company's core mission involves addressing significant unmet medical needs within the orphan drug sector, concentrating on severe and rare or niche diseases. Its current therapeutic pipeline includes two key drugs undergoing Phase IIb/III clinical trials: Aladote, which is designed to mitigate the risk of acute liver damage associated with acetaminophen/paracetamol poisoning, and Emcitate, intended for the management of MCT8 deficiency, a rare congenital disorder impacting thyroid hormone signaling. Established in 2006, Egetis Therapeutics AB (publ) is headquartered in Stockholm, Sweden, and was previously known as PledPharma AB (publ) until its name change in December 2020.
Hisse Fiyatı
$0.87679425
Son senkronizasyon: 2026-08-31
Piyasa Değeri
$407.66M
Değişim (1 gün)
-1.88%
Değişim (1 yıl)
58.03%
Ülke
SE
Ticaret Egetis Therapeutics AB (publ) (EGTX)

Kategori

Egetis Therapeutics AB (publ) (EGTX) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.82 - 2026-08-01

Gün sonu en düşük fiyat: $2.05 - 2011-04-01
Egetis Therapeutics AB (publ) için hisse fiyatı geçmişi: 2011 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) 16.80%
2025 -9.69%
2024 12.61%
2023 5.26%
2022 -32.21%
2021 -1.08%
2020 -64.01%
2019 24.17%
2018 -26.69%
2017 31.53%
2016 -66.48%
2015 78.45%
2014 56.36%
2013 68.37%
2012 3.47%
2011 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$544.38 39.22%
US
$1.03K 45.21%
NL
$121.37 -11.93%
AU
$138.80 476.17%
US
$749.90 5.10%
CH